To include your compound in the COVID-19 Resource Center, submit it here.

Ex-Synageva team planning Kiniksa IPO

Kiniksa Pharmaceuticals Ltd. (Hamilton, Bermuda) filed on April 27 to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, JMP Securities and Wedbush PacGrow.

Kiniksa Chairman

Read the full 324 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE